Failure of trimethoprim-sulfamethoxazole therapy in experimental enterococcal endocarditis.

To assess the potential efficacy of trimethoprim-sulfamethoxazole (TMP-SMX) against serious enterococcal infections, we used a rat enterococcal endocarditis model comparing TMP-SMX therapy (500 mg of TMP plus 2,500 mg of SMX per kg of body weight per day given every 8 h by intragastric gavage) with...

Descripció completa

Dades bibliogràfiques

Publicat a:	Antimicrob Agents Chemother
Autors principals:	Grayson, M L, Thauvin-Eliopoulos, C, Eliopoulos, G M, Yao, J D, DeAngelis, D V, Walton, L, Woolley, J L, Moellering, R C
Format:	Artigo
Idioma:	Inglês
Publicat:	American Society for Microbiology (ASM) 1990
Matèries:	Research Article
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC171927/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2126691/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.34.9.1792
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!